4//SEC Filing
FOSTER DAVID G 4
Accession 0001179110-20-004487
CIK 0000855654other
Filed
Apr 1, 8:00 PM ET
Accepted
Apr 2, 3:56 PM ET
Size
8.9 KB
Accession
0001179110-20-004487
Insider Transaction Report
Form 4
ImmunoGen, Inc.IMGN
FOSTER DAVID G
V.P.-Fin., Prin. Acctg. Off.
Transactions
- Exercise/Conversion
Restricted Share Unit
2020-04-01−18,160→ 27,240 totalExercise: $0.00→ Common Stock (18,160 underlying) - Exercise/Conversion
Common Stock
2020-04-01+18,160→ 26,830 total - Sale
Common Stock
2020-04-02$3.43/sh−5,448$18,687→ 21,382 total
Footnotes (4)
- [F1]Each restricted stock unit ("RSU") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock.
- [F2]On April 1, 2019, the reporting person was granted 45,000 restricted share units, vesting 40% on April 1, 2020 and 60% on December 31, 2020, subject to continued service through each such vesting date.
- [F3]Restricted stock units convert into common stock on a one-for-one basis
- [F4]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.36 to $3.50, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within these ranges.
Documents
Issuer
ImmunoGen, Inc.
CIK 0000855654
Entity typeother
Related Parties
1- filerCIK 0001177854
Filing Metadata
- Form type
- 4
- Filed
- Apr 1, 8:00 PM ET
- Accepted
- Apr 2, 3:56 PM ET
- Size
- 8.9 KB